The University of Chicago Header Logo

Connection

David Grdina to Radiation-Protective Agents

This is a "connection" page, showing publications David Grdina has written about Radiation-Protective Agents.
Connection Strength

7.659
  1. Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugs. Radiat Res. 2014 May; 181(5):464-70.
    View in: PubMed
    Score: 0.443
  2. SOD2-mediated effects induced by WR1065 and low-dose ionizing radiation on micronucleus formation in RKO human colon carcinoma cells. Radiat Res. 2011 Jan; 175(1):57-65.
    View in: PubMed
    Score: 0.349
  3. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):886-96.
    View in: PubMed
    Score: 0.310
  4. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha. Radiat Res. 2007 Apr; 167(4):465-74.
    View in: PubMed
    Score: 0.272
  5. Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065. Free Radic Biol Med. 2006 Mar 15; 40(6):1004-16.
    View in: PubMed
    Score: 0.247
  6. Radioprotectors: current status and new directions. Radiat Res. 2005 Jun; 163(6):704-5.
    View in: PubMed
    Score: 0.239
  7. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC). Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):553-63.
    View in: PubMed
    Score: 0.229
  8. Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice. Semin Oncol. 2002 Dec; 29(6 Suppl 19):22-8.
    View in: PubMed
    Score: 0.201
  9. Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine. Radiat Res. 2002 Jul; 158(1):101-9.
    View in: PubMed
    Score: 0.195
  10. Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):180-9.
    View in: PubMed
    Score: 0.193
  11. Relationships between cytoprotection and mutation prevention by WR-1065. Mil Med. 2002 Feb; 167(2 Suppl):51-3.
    View in: PubMed
    Score: 0.190
  12. Inhibition of spontaneous metastases formation by amifostine. Int J Cancer. 2002 Jan 10; 97(2):135-41.
    View in: PubMed
    Score: 0.189
  13. Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells. Semin Radiat Oncol. 2002 Jan; 12(1 Suppl 1):103-11.
    View in: PubMed
    Score: 0.189
  14. Radioprotectants: current status and new directions. Oncology. 2002; 63 Suppl 2:2-10.
    View in: PubMed
    Score: 0.189
  15. Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines. Int J Radiat Biol. 2000 May; 76(5):633-9.
    View in: PubMed
    Score: 0.168
  16. Further evidence that the radioprotective aminothiol, WR-1065, catalytically inactivates mammalian topoisomerase II. Cancer Res. 2000 Mar 01; 60(5):1186-8.
    View in: PubMed
    Score: 0.166
  17. Amifostine: mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol Drug Interact. 2000; 16(4):237-79.
    View in: PubMed
    Score: 0.164
  18. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells. Cell Prolif. 1997 Jun-Jul; 30(6-7):283-94.
    View in: PubMed
    Score: 0.137
  19. Andrographis paniculata Diterpenoids Protect against Radiation-Induced Transformation in BALB/3T3 Cells. Radiat Res. 2017 07; 188(1):66-74.
    View in: PubMed
    Score: 0.137
  20. The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutat Res. 1996 Sep 23; 356(2):147-54.
    View in: PubMed
    Score: 0.131
  21. Antimutagenic effects of amifostine: clinical implications. Semin Oncol. 1996 Aug; 23(4 Suppl 8):53-7.
    View in: PubMed
    Score: 0.130
  22. Expression of thymidine kinase messenger RNA and a related transcript is modulated by radioprotector WR1065. Cancer Res. 1995 Nov 01; 55(21):4788-92.
    View in: PubMed
    Score: 0.123
  23. The effects of cycloheximide and WR-1065 on radiation-induced repair processes: a mechanism for chemoprevention. Carcinogenesis. 1995 Nov; 16(11):2699-705.
    View in: PubMed
    Score: 0.123
  24. Protection against radiation-induced mutagenesis at the hprt locus by spermine and N,N"-(dithiodi-2,1-ethanediyl)bis-1,3-propanediamine (WR-33278). Mutagenesis. 1994 Jul; 9(4):355-60.
    View in: PubMed
    Score: 0.112
  25. Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065). Radiat Res. 1994 Apr; 138(1):44-52.
    View in: PubMed
    Score: 0.110
  26. Protection from radiation-induced apoptosis by the radioprotector amifostine (WR-2721) is radiation dose dependent. Cell Biol Toxicol. 2014 Feb; 30(1):55-66.
    View in: PubMed
    Score: 0.109
  27. Manganese superoxide dismutase interacts with a large scale of cellular and mitochondrial proteins in low-dose radiation-induced adaptive radioprotection. Free Radic Biol Med. 2012 Nov 15; 53(10):1838-47.
    View in: PubMed
    Score: 0.099
  28. Antimutagenic effects of radioprotector WR-2721 against fission-spectrum neurons and 60Co gamma-rays in mice. Int J Radiat Biol. 1992 Mar; 61(3):387-92.
    View in: PubMed
    Score: 0.096
  29. Reversion of radiosensitivity in azacytidine-treated XRS5 cells does not result in full radioprotection by WR-1065. Int J Radiat Oncol Biol Phys. 1992; 23(5):999-1002.
    View in: PubMed
    Score: 0.094
  30. Chemical protection and cell-cycle effects on radiation-induced mutagenesis. Cell Prolif. 1992 Jan; 25(1):23-9.
    View in: PubMed
    Score: 0.094
  31. Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326. Int J Radiat Oncol Biol Phys. 1992; 22(4):813-5.
    View in: PubMed
    Score: 0.094
  32. Protection by WR-2721 and WR-151327 against late effects of gamma rays and neutrons. Adv Space Res. 1992; 12(2-3):257-63.
    View in: PubMed
    Score: 0.094
  33. Misoprostol, a PGE1 analog, protects mice from fission-neutron injury. Radiat Res. 1991 Oct; 128(1 Suppl):S12-7.
    View in: PubMed
    Score: 0.093
  34. Protection by WR-151327 against late-effect damage from fission-spectrum neutrons. Radiat Res. 1991 Oct; 128(1 Suppl):S124-7.
    View in: PubMed
    Score: 0.093
  35. The effect of chemical radiation protectors on cell cycle progression after gamma or neutron irradiation. Cell Prolif. 1991 May; 24(3):271-80.
    View in: PubMed
    Score: 0.090
  36. Association of WR-1065 with CHO AA8 cells, nuclei, and nucleoids. Radiat Res. 1991 Feb; 125(2):152-7.
    View in: PubMed
    Score: 0.089
  37. Pathological effects of the radiation protector WR-151327 in mice. Radiat Res. 1990 Oct; 124(1):79-84.
    View in: PubMed
    Score: 0.087
  38. Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cells. Radiat Res. 2010 Feb; 173(2):175-83.
    View in: PubMed
    Score: 0.083
  39. Protection by WR1065 and WR151326 against fission-neutron-induced mutations at the HGPRT locus in V79 cells. Radiat Res. 1989 Mar; 117(3):500-10.
    View in: PubMed
    Score: 0.078
  40. Protection against radiation-induced mutagenesis in V79 cells by 2-[(aminopropyl)amino] ethanethiol under conditions of acute hypoxia. Radiat Res. 1989 Feb; 117(2):251-8.
    View in: PubMed
    Score: 0.077
  41. Radiation protectors: the unexpected benefits. Drug Metab Rev. 1989; 20(1):13-42.
    View in: PubMed
    Score: 0.077
  42. The effect of 2-[(aminopropyl)amino] ethanethiol on fission-neutron-induced DNA damage and repair. Br J Cancer. 1989 Jan; 59(1):17-21.
    View in: PubMed
    Score: 0.077
  43. Amifostine reduces lung vascular permeability via suppression of inflammatory signalling. Eur Respir J. 2009 Mar; 33(3):612-24.
    View in: PubMed
    Score: 0.076
  44. WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability. Free Radic Biol Med. 2008 Dec 15; 45(12):1674-81.
    View in: PubMed
    Score: 0.075
  45. Differential protection of radiation-induced DNA single-strand breaks and cell survival by solcoseryl. Experientia. 1988 Aug 15; 44(8):707-8.
    View in: PubMed
    Score: 0.075
  46. Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine. Int J Radiat Biol. 2008 Aug; 84(8):623-34.
    View in: PubMed
    Score: 0.075
  47. Cell cycle redistribution of cultured cells after treatment with chemical radiation protectors. Cell Tissue Kinet. 1988 May; 21(3):193-200.
    View in: PubMed
    Score: 0.073
  48. Radioprotectors in treatment therapy to reduce risk in secondary tumor induction. Pharmacol Ther. 1988; 39(1-3):21-5.
    View in: PubMed
    Score: 0.072
  49. Effects of radioprotectors on DNA damage and repair, proteins, and cell-cycle progression. Pharmacol Ther. 1988; 39(1-3):133-7.
    View in: PubMed
    Score: 0.072
  50. 2-[(Aminopropyl)amino] ethanethiol-mediated reductions in 60Co gamma-ray and fission-spectrum neutron-induced chromosome damage in V79 cells. Radiat Res. 1988 Jan; 113(1):145-54.
    View in: PubMed
    Score: 0.072
  51. Modification of radiation response in mice by fractionated extracts of Panax ginseng. Radiat Res. 1987 Oct; 112(1):156-63.
    View in: PubMed
    Score: 0.070
  52. Radiation-induced DNA single-strand breaks in the intestinal mucosal cells of mice treated with the radioprotectors WR-2721 or 16-16 dimethyl prostaglandin E2. Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Jul; 52(1):67-76.
    View in: PubMed
    Score: 0.069
  53. The effect of 2-[(aminopropyl)amino] ethanethiol (WR-1065) on radiation induced DNA double strand damage and repair in V79 cells. Br J Cancer. 1987 May; 55(5):477-82.
    View in: PubMed
    Score: 0.068
  54. The effect of 2-[(aminopropyl)amino] ethanethiol (WR1065) on radiation-induced DNA damage and repair and cell progression in V79 cells. Br J Cancer. 1986 Dec; 54(6):933-41.
    View in: PubMed
    Score: 0.066
  55. The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis. 1985 Jun; 6(6):929-31.
    View in: PubMed
    Score: 0.060
  56. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat Res. 2004 Nov; 162(5):536-46.
    View in: PubMed
    Score: 0.057
  57. Oral administration is as effective as intraperitoneal administration of amifostine in decreasing nitroxide EPR signal decay in vivo. Biochim Biophys Acta. 2003 Mar 20; 1637(2):151-5.
    View in: PubMed
    Score: 0.051
  58. Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Radic Biol Med. 2001 Jun 15; 30(12):1426-39.
    View in: PubMed
    Score: 0.045
  59. Radioprotection by WR-151327 against the late normal tissue damage in mouse hind legs from gamma ray radiation. Int J Radiat Oncol Biol Phys. 1994 Nov 15; 30(4):867-72.
    View in: PubMed
    Score: 0.029
  60. Accumulation of CHO cells in G2 phase following exposure to WR-1065. Radiat Res. 1991 May; 126(2):223-8.
    View in: PubMed
    Score: 0.023
  61. Conformational changes in chromatin structure induced by the radioprotective aminothiol, WR 1065. Br J Cancer. 1989 Dec; 60(6):893-6.
    View in: PubMed
    Score: 0.020
  62. Protective effects of 2-[(aminopropyl)amino] ethanethiol against bleomycin and nitrogen mustard-induced mutagenicity in V79 cells. Int J Radiat Oncol Biol Phys. 1986 Aug; 12(8):1475-8.
    View in: PubMed
    Score: 0.016
  63. A comparison of radioprotection from three neutron sources and 60Co by WR-2721 and WR-151327. Radiat Res. 1986 May; 106(2):224-33.
    View in: PubMed
    Score: 0.016
  64. Protection against cis-diamminedichloroplatinum cytotoxicity and mutagenicity in V79 cells by 2-[(aminopropyl)amino]ethanethiol. Cancer Res. 1986 Mar; 46(3):1132-5.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.